Condition
Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) clinical trials that are recruiting, at sites in 3 countries (most in China (2), Switzerland (1), France (1)). By phase: Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 3Countries
Newest Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Pregnant Women with Neuroimmune Diseases: A long-term follow-up study | — | Guangzhou, Guangdong | Recruiting | Jun 17, 2026 |
| Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain | — | Marseille | Recruiting | Oct 1, 2025 |
| National registry for pediatric inflammatory brain diseases in Switzerland | — | Aarau, Canton of Aargau and 12 other locations | Recruiting | Aug 23, 2021 |
| Using CT103A cells to treat autoimmune diseases of the nervous system | Early Phase 1 | Wuhan, Hubei | Recruiting | Sep 23, 2020 |
All recruiting trials (4)
-
Pregnant Women with Neuroimmune Diseases: A long-term follow-up study
This study follows women with neuroimmune diseases and healthy controls through pregnancy and up to ten years to see how pregnancy affects disease activity and outcomes for both mother and baby.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
-
National registry for pediatric inflammatory brain diseases in Switzerland
This study is collecting information on children with inflammatory brain diseases in Switzerland to see how to better diagnose and treat these conditions.
-
Using CT103A cells to treat autoimmune diseases of the nervous system
This study is testing if a new treatment using CT103A cells can help people with certain autoimmune diseases affecting the nervous system feel better.
Related topics
Quick answers
How many Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 3 countries. The most sites are in China (2 trials), Switzerland (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.